Northrop Grumman Corporation (NOC) — BATS 0/100 — 2026-07-21

Listen to the earnings call audio for free on StockAnalysis

Summary based on Northrop Grumman Corporation earnings call on 2026-07-21

BotFlo AI Transformation Score for $NOC: 0 (0/100)

Sector AI Transformation Score for $NOC: 0 (0/50)

Presentation

(1/8) Opening pride in mission and technology heritage
• 🇺🇸 Kathy Warden opens by tying America’s 250th birthday and the B-2 July 4 flyover to Northrop Grumman’s role protecting freedom.
• ✈️ She highlights signature technologies from the world’s fastest microchip and James Webb Space Telescope to B-2 and B-21 flying-wing stealth.
• ⚡ The company is operating with urgency to deliver quality capabilities at speed for a dynamic threat environment.

(2/8) U.S. and allied defense budget tailwinds
• 📈 House and Senate panels supported a $1.1 trillion Department of War base budget, nearly 10% above fiscal year 2026.
• 💰 A $67 billion supplemental and a $350 billion reconciliation package are under consideration to modernize capabilities and the industrial base.
• 🌍 Global allies are accelerating modernization, including NATO pledges and Middle East missile-defense demand.

(3/8) International awards and production-ready demand
• 🛰️ NATO Summit pledges included commitment interest for Northrop Grumman’s Triton autonomous aircraft.
• 🛡️ Momentum is building for IBCS, including State Department authorization for six systems for Kuwait.
• 🏭 Australia selected Northrop Grumman to establish an in-country solid rocket motor manufacturing facility.

(4/8) Q2 results, backlog, and raised 2026 guidance
• 📊 Northrop Grumman booked $20 billion in net awards, a 1.84x book-to-bill, and a record $105 billion backlog.
• 📈 Sales rose 5% with growth in all four segments, and management raised full-year sales midpoint to $44 billion and EPS by $1.20.
• ⚠️ Lower DS and Space margin rates reflected negative EAC adjustments on SiAW and GEM 63XL despite confidence in eventual delivery.

(5/8) Sentinel, multiyear missiles, and capacity investments
• 🚀 Sentinel progress added $7.6 billion of backlog, with acoustic testing complete and first flight targeted in 2027.
• 🏗️ Northrop broke ground on another advanced Utah facility to support Sentinel production later this decade.
• 💣 PAC-3 SRM qualification and a $2 billion framework agreement support up to $10 billion of multiyear missile sales opportunity over seven years.

(6/8) National security space and Mission Robotic Vehicle
• 🛰️ National security space backlog exceeds $16 billion and is projected over $7 billion in sales, more than 15% of company revenues.
• 🤖 The Mission Robotic Vehicle is described as the first commercial robotics spacecraft with two arms to repair, relocate, and service GEO satellites.
• 📅 The first MRV was scheduled to launch the same day, weather permitting.

(7/8) CFO review of quarterly financials
• 💵 Q2 sales were $10.9 billion, up 5% year over year and 10% sequentially, with EPS of $7.68.
• 🔧 CapEx was $302 million and Q2 adjusted free cash flow nearly $1 billion as facilities expand for demand.
• 📉 Segment operating income decreased slightly versus a prior year that included a $76 million favorable Sentinel EAC.

(8/8) Segment performance and full-year outlook detail
• ✈️ Aeronautics delivered 13% sales growth and a 10.3% margin rate on B-21, TACAMO, and mature production strength.
• 📊 Company sales guidance rose to $43.75–$44.25 billion and MTM-adjusted EPS to $28.60–$29.10, with FCF and segment OI largely reaffirmed.
• 🧭 Segment guides raise AS sales and margins, hold DS and MS sales with MS margin up, and lower Space margin to the low 10% range after GEM pressure.

Q&A

(1/16) Q&A: Drivers of the $1.20 full-year EPS guidance increase and tax impact
• 💰 John Greene says higher full-year EPS reflects sales execution, strong second-half margins, a tax benefit, and operating-cost efficiency—not tax alone.
• 📋 The uncertain tax position adjustment pulled forward benefit in the current quarter.
• 📈 Management stresses operations are strong and expects a really strong second half.

(2/16) Q&A: What is driving higher SiAW development costs
• ⚠️ Kathy Warden links SiAW cost growth to testing delays on AARGM-ER, the technology basis for Stand-In Attack Weapon.
• 🛠️ The company is investing more resources and better integration lab facilities to accelerate testing.
• 🎯 High U.S. Navy, Air Force, and international demand makes clearing performance challenges a priority.

(3/16) Q&A: Returns on past investment and forward CapEx ROI
• 📈 Warden says capability investments such as GEM 63XL, SiAW, B-21, and Golden Dome offerings are positioning top-line growth now visible in a 1.25 book-to-bill outlook.
• 🏭 Capacity investments, including ammunition and PAC-3 MSE readiness, enable earlier revenue than would otherwise be possible.
• 💵 Investments are made with disciplined business cases so that after development risk, production generates strong returns.

(4/16) Q&A: HALO revenue pressure and NASA gateway changes
• 🛰️ NASA is moving away from original gateway plans, and Northrop is restructuring HALO so the technology still contributes to future plans.
• 📉 The change reduces revenue this year as outlined in filings.
• ⏳ Revenue is expected to extend over a longer period as deliverables align to the new NASA plan.

(5/16) Q&A: PAC-3 qualification timing, capacity, and DS second-half drivers
• ✅ Qualification is complete, production capacity exists, and builds are starting ahead of a definitized contract later this year.
• 📜 A larger production contract is expected later this year as FY27 appropriations funding becomes available.
• 📊 Second-half strength is broad across all four businesses, with natural seasonality and a path to about 5% full-year growth.

(6/16) Q&A: B-21 program-of-record expansion and Aero margin strength
• ✈️ The Air Force agreement allows consideration of accelerating production into a larger program of record, with analysis expected to conclude by year-end.
• 📈 Aero margin strength has been a mix of good B-21 execution and favorable EACs on mature production programs.
• 🏭 Strong manufacturing processes and milestone delivery have kept AS margins stable and trending upward.

(7/16) Q&A: Defense and commercial space demand and MRV plans
• 🚀 National security space—including resiliency, ISR, and missile defense—is among the strongest U.S. budget and company growth areas at about 15% of revenues.
• 🌍 International space demand and pipeline are also increasing, with different exportable offerings.
• 🤖 MRV adds robotic-arm servicing under a commercial invest-and-deploy model, expected to become operational in 2027 after orbit and testing.

(8/16) Q&A: PAC-3 market share and DS longer-term growth versus 7% CAGR
• 🧩 As a new PAC-3 supplier, Northrop will start smaller and scale over time if early production performance builds credibility.
• 📊 Greene focuses on the current year and avoids detailed outer-year targets pending strategic planning work.
• 📈 Strong book-to-bill, Sentinel, B-21, and weapons demand are cited as drivers that should enable faster revenue growth over time than historical rates.

(9/16) Q&A: 2027 growth optimism and free cash flow versus higher CapEx
• 🔮 Warden refrains from a 2027 growth number but cites 1.25 book-to-bill, double-digit international growth, and mix shift toward production margins as reasons for optimism.
• 💵 Operating cash flow is up about 30% from 2023 through the current year as the business generates substantial cash.
• 🏗️ CapEx around 4.5% of sales will be managed to convert operating cash to free cash flow, with refined 2027–2028 views later in the year while still investing to meet demand.

(10/16) Q&A: Unmanned Triton demand and Golden Dome status
• 🛩️ NATO interest in up to five Tritons is expected to move toward contract next year, supporting surveillance in the high north with a mature production program.
• 🌐 International growth is broad-based across munitions, IBCS, E-2D, and other offerings, not only unmanned systems.
• 🛡️ Golden Dome is a collection of competitions and sole-source adds; reconciliation funding accelerated in Q2 and related revenues should continue to scale.

(11/16) Q&A: Microelectronics foundry business outlook
• 🔌 Microelectronics continues to serve government and commercial customers but faces program life-cycle dynamics and lower growth this year in restricted areas.
• 🔗 The business remains an important vertical-integration enabler across MS, Space, Aeronautics, and DS weapons.
• 📈 Underlying external demand for secure processing is still robust and expected to increase over time.

(12/16) Q&A: DS and Space second-half margins as 2027 jumping-off point; offensive MRV
• 📊 Greene notes DS margins are about 11% excluding the one program issue and expresses confidence in strong margins through the second half and into next year without prescribing a model.
• 🛰️ On an offensive MRV variant, Warden defers mission and policy choices to the U.S. government.
• ⚖️ She will not qualitatively size a hostile satellite-disablement market for MRV.

(13/16) Q&A: Marine business growth and Middle East IBCS plus FMS reforms
• 🚢 Marine growth is led by nuclear propulsion modernization moving from development into production and LRIP scaling through this decade and the next.
• 🛡️ Beyond Kuwait’s six IBCS systems, LORs from UAE and Qatar and talks with other Middle East countries reflect missile-defense urgency.
• ⏩ FMS cases are being approved much faster than in prior years due to administration cross-agency focus.

(14/16) Q&A: Confidence in DS tactical missile cost growth and second-half margins
• 🔍 Independent resources were brought in to shore up EAC assumptions, supporting confidence the plan is executable.
• 👥 Added people and infrastructure plus customer agreement keep Northrop in lockstep on required deliverables.
• ⚠️ Qualification risk remains until complete, but management feels it has a good executable plan and will provide updates.

(15/16) Q&A: $10 billion SRM opportunity pricing and inflation protection
• 📝 Detailed price and fee negotiations with the Department of War and primes are still ahead under existing framework agreements.
• ⏳ Finer contract points should work through this year and possibly early next as funding becomes available.
• 💵 With capacity and qualification largely in hand, deals should resemble mature production programs, with risk incorporated into pricing discipline.

(16/16) Q&A: Sentinel positive EAC versus AARGM investment and space-based AMTI posture
• ⚖️ Greene agrees it is fair to think a positive Sentinel adjustment was effectively offset by higher AARGM-related investment, without breaking out a small item.
• 📡 Space-based AMTI/GMTI is an attractive market where Northrop has capability and will look at future requirement tranches.
• 🎯 Closing remarks reaffirm global demand, base-budget support, second-half margin recovery, and commitment to the raised sales and EPS guide.